Fondaparinux (Arixtra) Table    body {font-family: 'Open Sans', sans-serif;}

### Fondaparinux (Arixtra) and Neuraxial Block

table.tableizer-table { font-size: 12px; border: 1px solid #CCC; font-family: Arial, Helvetica, sans-serif; } .tableizer-table td { padding: 4px; margin: 3px; border: 1px solid #CCC; } .tableizer-table th { background-color: #104E8B; color: #FFF; font-weight: bold; }

| Minimal Time between  
last dose and neuraxial procedure | Can it be given with  
epidural catheter in place? | Restart after  
neuraxial procedure and/or  
catheter insertion | Restart after  
catheter removal |
| --- | --- | --- | --- |
| ASRA has no recommendation  
  
Other source:  
48 hours with CrCl â‰¥ 30 ml/min  
If CrCl < 30 ml/min: Call Hematology. | ASRA: Avoid  
  
Avoid | ASRA: Avoid  
  
Avoid | ASRA: 6 hours  
after catheter removal |

  
**Deep plexus and peripheral blocks:** Avoid.**Superficial peripheral blocks:** Based on vascularity, site compressibility and available management if bleeding occurred.  
  
**Labs:**  
Anti-Xa assay.  
Always refer to the latest ASRA (American Society of Regional Anesthesia and Pain) Recommendations  
https://www.asra.com/advisory-guidelines  
  
ASRA Assistance:  
Toll free in US: 855-795-ASRA (2772)  
412-471-2718  
asraassistant@asra.com